US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...